Hepatocyte Growth Factor and Cardiovascular Autonomic Function

This study has been completed.
Sponsor:
Information provided by:
Oita Red Cross Hospital
ClinicalTrials.gov Identifier:
NCT00478127
First received: May 23, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted

May 23, 2007
May 23, 2007
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Hepatocyte Growth Factor and Cardiovascular Autonomic Function
Not Provided

In this study, we tested the hypothesis that elevated HGF is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients not receiving insulin treatment.

Not Provided
Observational
Allocation: Random Sample
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Not Provided
Not Provided
Type-2 Diabetes
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Type-2 diabetes

Exclusion Criteria:

  • Type-1 diabetes
Both
Not Provided
Not Provided
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00478127
AO-272
Not Provided
Not Provided
Oita Red Cross Hospital
Not Provided
Principal Investigator: Futoshi Anan Oita Red Cross Hospital
Oita Red Cross Hospital
May 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP